Michael R. Shurin
Department of Pathology
UPMC, 3550 Terrace Street
Scaife Hall S735
USA
Name/email consistency: high
- ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents. Shurin, M.R., Naiditch, H., Gutkin, D.W., Umansky, V., Shurin, G.V. Curr. Med. Chem. (2012)
- Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer. Shurin, M.R., Potapovich, A.I., Tyurina, Y.Y., Tourkova, I.L., Shurin, G.V., Kagan, V.E. Cancer Res. (2009)
- Immune-Mediated Diseases II Congress: summary. Shurin, M.R., Smolkin, Y.S. J. Immunotoxicol (2008)
- Aging and the dendritic cell system: implications for cancer. Shurin, M.R., Shurin, G.V., Chatta, G.S. Crit. Rev. Oncol. Hematol. (2007)
- Immune-mediated diseases: where do we stand?. Shurin, M.R., Smolkin, Y.S. Adv. Exp. Med. Biol. (2007)
- Immune-mediated diseases: from theory to therapy. 10-15 September 2007, Moscow, Russia. Shurin, M.R. IDrugs (2007)
- Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Shurin, M.R., Shurin, G.V., Lokshin, A., Yurkovetsky, Z.R., Gutkin, D.W., Chatta, G., Zhong, H., Han, B., Ferris, R.L. Cancer Metastasis Rev. (2006)
- Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. Shurin, G.V., Ferris, R.L., Ferris, R., Tourkova, I.L., Perez, L., Lokshin, A., Balkir, L., Collins, B., Chatta, G.S., Shurin, M.R. J. Immunol. (2005)
- Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand. Shurin, G.V., Chatta, G.S., Tourkova, I.L., Zorina, T.D., Esche, C., Shurin, M.R. Exp. Gerontol. (2004)